Chinese weight-correction model for maternal serum markers in Down syndrome prenatal screening

被引:2
|
作者
Wang, Yuan-Yuan
Zhang, Li
Peng, Zuo-Qi
Cui, Qin-Zi
Ma, Xu
机构
[1] Natl Res Inst Family Planning, Beijing 100081, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] WHO Collaborating Ctr Res Human Reprod, Beijing, Peoples R China
[4] Sheng Yang Maternal & Child Hlth Hosp, Liaoning, Peoples R China
关键词
Down syndrome; prenatal screening; regression model; weight-correction model;
D O I
10.1016/j.ijgo.2006.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the best weight-correction model by means of analyzing the relationship between maternal weight and maternal serum markers when screening for Down syndrome in China. Methods: Serum levels of (x-fetoprotein (AFP) and free beta-human chorionic gonadotropin (hCG) were measured in 35,917 Chinese women during the second semester of a normal singleton pregnancy and converted to multiple of median (MoM) values. Using 2 methods of statistical analysis, the all-point method and the median regression method, 4 weightcorrection models were then tried, the simple linear, reciprocal, quadratic, and log-linear regression models. Results: The median regression method performed better than the all-point method, and the quadratic regression model showed the best fit for both AFP and hCG in the median regression method, with adjusted R(2)s of 0.987 and 0.988, respectively. Conclusion: The quadratic regression model was found to be the most suitable for Chinese pregnant women. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [31] Maternal weight and first trimester Down syndrome screening.
    Palomaki, GE
    Neveux, LM
    Knight, GJ
    Haddow, JE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A160 - A160
  • [32] Quality assurance of markers in integrated prenatal screening for Down syndrome.
    Meier, C
    Huang, T
    Summers, AM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 411 - 411
  • [33] PRENATAL SCREENING FOR DOWN SYNDROME
    SELLER, MJ
    LANCET, 1984, 1 (8390): : 1359 - 1359
  • [34] Verification of foetal Down syndrome biomarker proteins in maternal plasma and applications in prenatal screening for Down syndrome
    Weiguo Sui
    Qing Gan
    Wei Wei Gong
    Xiaolian Wei
    Minglin Ou
    Donge Tang
    Huanyun Jing
    Hua Lin
    Yue Zhang
    Yong Dai
    Translational Medicine Communications, 3 (1)
  • [35] Prenatal screening for Down syndrome
    Ogle, RF
    Chitty, LS
    HOSPITAL MEDICINE, 1998, 59 (08): : 632 - 636
  • [36] PRENATAL SCREENING FOR DOWN SYNDROME
    SELLER, MJ
    JOURNAL OF MEDICAL GENETICS, 1985, 22 (04) : 321 - 323
  • [37] Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome
    Cuckle, HS
    Holding, S
    Jones, R
    Groome, NP
    Wallace, EM
    PRENATAL DIAGNOSIS, 1996, 16 (12) : 1095 - 1100
  • [38] PRENATAL RISK INDEX FOR FETAL DOWN-SYNDROME BY SERUM MARKERS
    BARTELS, I
    SANCKEN, U
    ZEITSCHRIFT FUR GEBURTSHILFE UND PERINATOLOGIE, 1994, 198 (04): : 153 - 154
  • [39] Prenatal Screening Using Maternal Markers
    Cuckle, Howard
    JOURNAL OF CLINICAL MEDICINE, 2014, 3 (02) : 504 - 520
  • [40] THE EFFECT OF MATERNAL WEIGHT ADJUSTMENT ON SCREENING FOR DOWN-SYNDROME USING MATERNAL SERUM ALPHA-FETOPROTEIN AND AGE
    HADDOW, JE
    PALOMAKI, GE
    KNIGHT, GJ
    WILLIAMS, JR
    BEAUREGARD, LJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 222 - 222